Towards regenerative medicine strategy and new drug development for kidney diseases using iPSC technology

被引：0
|
作者：
Osafune, Kenji [1 ]
机构：
[1] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068501, Japan
来源：
JOURNAL OF PHYSIOLOGICAL SCIENCES | 2013年 / 63卷
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [21] Drug Development for Cystic Kidney Diseases
    Fedeles, Sorin
    Perrone, Ronald D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (10): : 1549 - 1550
  • [22] Drug screening for human genetic diseases using iPSC models
    Elitt, Matthew S.
    Barbar, Lilianne
    Tesar, Paul J.
    HUMAN MOLECULAR GENETICS, 2018, 27 (R2) : R89 - R98
  • [23] Future trends and possibilities of using induced pluripotent stem cells (iPSC) in regenerative medicine
    Tucak, A.
    Vrabac, Dz.
    Smajic, A.
    Sazic, A.
    PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING 2017 (CMBEBIH 2017), 2017, 62 : 459 - 464
  • [24] Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease
    Pasteuning-Vuhman, Svetlana
    de Jongh, Rianne
    Timmers, Annabel
    Pasterkamp, R. Jeroen
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (03) : 263 - 279
  • [25] Development of Vascularized iPSC Derived 3D-Human Tissue Constructs for Regenerative Medicine
    Matsusaki, M.
    Akashi, M.
    TISSUE ENGINEERING PART A, 2015, 21 : S48 - S48
  • [26] Towards a personalized drug development using autologous iPSC-derived Multi-Organ-Chips
    Ramme, A.
    Koenig, L.
    Faust, D.
    Jaschke, M.
    Nguyen, N.
    Dehne, E. -M.
    Marx, U.
    TOXICOLOGY LETTERS, 2021, 350 : S61 - S61
  • [27] Development of a personalized regenerative medecine using iPSC for treating inherited liver diseases: application to Crigler-Najjar type 1
    Poiron, Claire
    Fourrier, Angelique
    Abarrategui-Pontes, Cecilia
    Fink, Kyle D.
    Lescaudron, Laurent
    Dunbar, Gary L.
    Gaignerie, Anne
    Weber, Anne
    Dubart-Kupperschmitt, Anne
    Fekir, Khadidja
    Vallier, Ludovic
    Labrune, Philippe
    Anegon, Ignacio
    Tuan Huy Nguyen
    HUMAN GENE THERAPY, 2012, 23 (10) : A89 - A90
  • [28] PHARMACOLOGICAL PROPERTIES OF PEGYLATED HYALURONIDASE - THE NEW DRUG FOR REGENERATIVE MEDICINE
    Zhdanov, V.
    Dygai, A.
    Zyuz'kov, G.
    Artamonov, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 139 - 139
  • [29] REGENERATIVE MEDICINE: A PROPOSED CLASSIFICATION FOR HEOR BASED ON THERAPEUTIC STRATEGY AND TECHNOLOGY TYPE
    Purser, M.
    Mladsi, D. M.
    VALUE IN HEALTH, 2018, 21 : S92 - S92
  • [30] THE STRATEGY FOR NEW DRUG DEVELOPMENT
    STEVENS, MFG
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 865 - 865
12345